In this Section |
269221 Harm reduction isn't just for drug users anymore! How abortion pills can reduce the harms of self-induced abortion for women globallyWednesday, October 31, 2012
: 9:00 AM - 9:15 AM
The term harm reduction defines policies, programs and practices seeking to reduce harms associated with an activity rather than eliminating the activity altogether. This term originated in drug-use prevention work to advocate for needle exchange programs to reduce HIV transmission and has since been applied to other public health issues. Harms associated with unsafe abortion have been widely documented. With the advent of abortion pills, also known as medical abortion, the landscape of unsafe abortion is quickly changing. Women increasingly find and obtain information and pills from pharmacists, medicine sellers, community midwives, market women, friends, family, and the Internet. Although WHO defines unsafe abortion as a procedure carried out by someone lacking necessary skills and/or in an environment that does not meet minimum medical standards, this definition comes from the late 1980s when most abortions were surgical. Abortion pills have since redefined the specific “skills” and “environment” characterizing unsafe abortion. Evidence shows that widespread use of abortion pills, both within and outside formal health-care facilities, has made self-induced abortion safer. The core principles of harm reduction—neutrality, humanism, and pragmatism—offer a conceptual framework for making medical abortion information and care available directly to women through a variety of creative means. This presentation will describe examples and lessons learned from the application of this successful public health paradigm to reduce unsafe abortion globally.
Learning Areas:
Implementation of health education strategies, interventions and programsSocial and behavioral sciences Systems thinking models (conceptual and theoretical models), applications related to public health Learning Objectives: Keywords: Abortion, International Reproductive Health
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been the co-leader of Ipas's harm reduction project team focusing on the exploration and application of harm reduction theory and practice to the field of abortion and particularly medical abortion. As a Senior Associate, I provide technical assistance to Ipas's country programs implemeting harm reduction strategies to reduce unsafe abortion. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 5087.0: Update on reproductive health and abortion
|